Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Inosine Pranobex Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

date 13 Jan 2025

date Pharma & Healthcare

new_biaoQian Inosine Pranobex

According to our (Global Info Research) latest study, the global Inosine Pranobex market size was valued at US$ 216 million in 2024 and is forecast to a readjusted size of USD 250 million by 2031 with a CAGR of 2.1% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Inosine Pranobex Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Pharma & Healthcare

new_biaoQian Inosine Pranobex

The global Inosine Pranobex market size is expected to reach $ 239.3 million by 2030, rising at a market growth of 2.1% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Inosine Pranobex Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Inosine Pranobex

According to our (Global Info Research) latest study, the global Inosine Pranobex market size was valued at USD 206.8 million in 2023 and is forecast to a readjusted size of USD 239.3 million by 2030 with a CAGR of 2.1% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Inosine Pranobex Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

new_biaoQian Inosine Pranobex

Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

USD3480.00

Add To Cart

Add To Cart

industry 13 Jan 2025

industry Pharma & Healthcare

new_biaoQian Inosine Pranobex

According to our (Global Info Research) latest study, the global Inosine Pranobex market size was valued at US$ 216 million in 2024 and is forecast to a readjusted size of USD 250 million by 2031 with a CAGR of 2.1% during review period.

USD3480.00

addToCart

Add To Cart

industry 10 Feb 2024

industry Pharma & Healthcare

new_biaoQian Inosine Pranobex

The global Inosine Pranobex market size is expected to reach $ 239.3 million by 2030, rising at a market growth of 2.1% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Inosine Pranobex

According to our (Global Info Research) latest study, the global Inosine Pranobex market size was valued at USD 206.8 million in 2023 and is forecast to a readjusted size of USD 239.3 million by 2030 with a CAGR of 2.1% during review period.

USD3480.00

addToCart

Add To Cart

industry 18 Mar 2023

industry Pharma & Healthcare

new_biaoQian Inosine Pranobex

Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

USD3480.00

addToCart

Add To Cart